Self-reported psychopathology among young, low-income, female ecstasy users

Journal of Addictive Diseases

Volumn 27, Issue 4, 2008, Pages 81-90

  Wu, Z Helen ^a,d   Baillargeon, Jacques G ^b   Berenson, Abbey B ^a   Holzer, Charles E ^c  

^a Center for Interdisciplinary Research in Women's Health   (United States)

^b Department of Preventive Medicine and Community Health   (United States)

^c University of Texas Medical Branch School of Medicine   (United States)

^d UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

Author keywords

Ecstasy; Psychopathology; Women; YASR

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; CANNABIS; ILLICIT DRUG; PSYCHEDELIC AGENT; STREET DRUG;

ADULT; ARTICLE; CANNABIS ADDICTION; CONTROLLED STUDY; DELINQUENCY; DISEASE SEVERITY; DRUG ABUSE; FEMALE; HUMAN; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MENTAL DISEASE; PREVALENCE; SELF REPORT; THOUGHT DISORDER; UNITED STATES; ADDICTION; ADOLESCENT; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDY; JUVENILE DELINQUENCY; OUTPATIENT DEPARTMENT; POVERTY; PSYCHIATRIC DIAGNOSIS; PSYCHOLOGICAL ASPECT; SELF EVALUATION; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; ADOLESCENT; ADULT; AMBULATORY CARE FACILITIES; ANALYSIS OF VARIANCE; CROSS-SECTIONAL STUDIES; DIAGNOSIS, DUAL (PSYCHIATRY); FEMALE; HALLUCINOGENS; HUMANS; JUVENILE DELINQUENCY; MENTAL DISORDERS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; POVERTY; PREVALENCE; PSYCHOPATHOLOGY; SELF ASSESSMENT (PSYCHOLOGY); STREET DRUGS; SUBSTANCE-RELATED DISORDERS; TEXAS; YOUNG ADULT;

EID: 63249126881     PISSN: 10550887     EISSN: 15450848     Source Type: Journal    
DOI: 10.1080/10550880802324895     Document Type: Article

References (41)

1. Milani RM, Parrott AC, Turner JJ, Fox HC. Gender differences in self-reported anxiety, depression, and somatization among ecstasy/MDMA polydrug users, alcohol/tobacco use rs, and nondrug users. Addict Behav. 2004;29:965-71.
2. Schuster P, Lieb R, Lamertz C, Wittchen HU. Is the use of ecstasy and hallucinogens increasing? Results from a community study. Eur Addict Res. 1998;4(1-2):75-82.
3. Wu ZH, Holzer CE III, Breitkopf CR, Grady JJ, Berenson AB. Patterns and perceptions of ecstasy use among young, low-income women. Addict Behav. 2006;31:676-85.
4. MDMA (Ecstasy) abuse. National Institute on Drug Abuse Research Report Series. Bethesda (MD): National Institutes of Health; 2006. NIH Publication No. 06-4728. [updated July 22, 2008; cited August 26, 2008]. Available from: http://www.drugabuse.gov/ResearchReports/ MDMA/default.html.
5. Arria AM, Yacoubian GS Jr, Fost E, Wish ED. The pediatric forum: ecstasy use among club rave attendees. Arch Pediatr Adolesc Med. 2002;156:295-6.
6. Gross SR, Barrett SP, Shestowsky JS, Pihl RO. Ecstasy and drug consumption patterns: a Canadian rave population study. Can J Psychiatry. 2002;47:546-51.
7. Sullivan G. Raving on the Internet. CMAJ. 2000;162:1864.
8. Yacoubian GS Jr, Arria AM, Fost E, Wish ED. Estimating the prevalence of Ecstasy use among juvenile offenders. J Psychoactive Drugs. 2002;34:209-13.
9. Yacoubian GS Jr. Correlates of ecstasy use among students surveyed through the 1997 College Alcohol Study. J Drug Educ. 2003;33:61-9.
10. Yacoubian GS Jr. Assessing the temporal relationship between race and ecstasy use among high school seniors. J Drug Educ. 2002;32:213-25.
11. Wish ED, Fitzelle DB, O'Grady KE, Hsu MH, Arria AM. Evidence for significant polydrug use among ecstasy-using college students. J Am Coll Health. 2006;55:99-104.
12. Meara E. Welfare reform, employment, and drug and alcohol use among low-income women. Harv Rev Psychiatry. 2006;14:223-32.
13. Montoya ID, Brown VL. The association between EIC receipt and employment in a sample of drug using and non-drug using TANF recipients. Am J Drug Alcohol Abuse. 2006;32:189-201.
14. Pollack HA, Reuter P. Welfare receipt and substance-abuse treatment among low-income mothers: the impact of welfare reform. Am J Public Health. 2006;96:2024-31.
15. Daumann J, Pelz S, Becker S, Tuchtenhagen F, Gouzoulis-Mayfrank E. Psychological profile of abstinent recreational Ecstasy (MDMA) users and significance of concomitant cannabis use. Hum Psychopharma-col. 2001;16:627-33.
16. Daumann J, Hensen G, Thimm B, Rezk M, Till B, Gouzoulis-Mayfrank E. Self-reported psychopatholog-ical symptoms in recreational ecstasy (MDMA) users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation. Psychopharmacology (Berl). 2004;173:398-404.
17. Roiser JP, Sahakian BJ. Relationship between ecstasy use and depression: a study controlling for poly-drug use. Psychopharmacology (Berl). 2004;173:411-7.
18. Gouzoulis-Mayfrank E, Daumann J. The confounding problem of polydrug use in recreational ecstasy/MDMA users: a brief overview. J Psychopharmacol. 2006;20:188-93.
19. Sobell LC, KwanE, Sobell MB. Reliability of a drug history questionnaire (DHQ). Addict Behav. 1995;20:233-41.
20. Huba GJ, Melchior LA, Staff of The Measurement Group, HRSA/HAB's SPNS Cooperative Agreement Steering Committee. Module 24: Brief substance abuse history form (1997). Culver City (Calif): The Measurement Group. [updated June 18, 1998; cited August 26, 2008]. Available from: http://www. themeasurementgroup. com/modules/mods/module24.htm.
21. Johnston LD, Bachman JG, O'Malley PM. Monitoring the future: a continuing study of American youth (12th-grade survey), 1999 Computer file]. University of Michigan, Inter-university Consortium for Political and Social Research; 2006. ICPSR Study No. 2939. [updated Sept. 17, 2007; cited August 26, 2008]. Available from: http:// www.icpsr.umich.edu/cocoon/ICPSR/STUDY/02939.xml.
22. Achenbach TM. Manual for the Young Adult Self-Report and Young Adult Behavior Checklist. Burlington, VT: University of Vermont, Department of Psychiatry; 1997.
23. SAS Institute Inc. SAS/STAT 9.1: User's Guide. Cary (NC): SAS Publishing; 2004.
24. Morgan MJ, McFie L, Fleetwood H, Robinson JA. Ecstasy (MDMA): are the psychological problems associated with its use reversed by prolonged abstinence? Psy-chopharmacology (Berl). 2002;159:294-303.
25. Kandel D, Yamaguchi K. From beer to crack: developmental patterns of involvement in drugs. Am J Public Health. 1993;83:851-5.
26. Kandel DB, Yamaguchi K. Developmental stages of involvement in substance use. In: Ott PJ, Tarter RE, Am-merman RT, eds. Sourcebook on substance abuse: etiology, epidemiology, assessment, and treatment. Boston: Allyn & Bacon; 1999. p. 50-74.
27. Zimmermann P, Wittchen HU, Waszak F, Nocon A, Hofler M, Lieb R. Pathways into ecstasy use: the role of prior cannabis use and ecstasy availability. Drug Alcohol Depend. 2005;79:331-41.
28. Andrews JA, Tildesley E, Hops H, Li F. The influence of peers on young adult substance use. Health Psychol. 2002;21:349-57.
29. Robin SS, Johnson EO. Attitude and peer cross pressure: adolescent drug and alcohol use. J Drug Educ. 1996;26:69-99.
30. Oostveen T, Knibbe R, de Vries H. Social influences on young adults' alcohol comsuption: norms, modeling, pressure, socializing, and conformity. Addict Behav. 1996;21:187-97.
31. Urberg KA, Luo Q, Pilgrim C, Degirmencioglu SM. A two-stage model of peer influence in adolescent substance use: individual and relationship-specific differences in susceptibility to influence. Addict Behav. 2003;28:1243-56.
32. Goode E. Marijuana use and the progression to dangerous drugs. In: Miller LL, editor. Marijuana: effects on human behavior. New York: Academic Press; 1974. p. 303-38.
33. Huba GJ, Wingard JA, Bentler PM. A comparison of two latent variable causal models for adolescent drug use. J Pers Soc Psychol. 1981;40:180-93.
34. Agrawal A, Neale MC, Prescott CA, Kendler KS. Cannabis and other illicit drugs: comorbid use and abuse/dependence in males and females. Behav Genet. 2004;34:217-28.
35. JessorR,Jessor SL. Problem behavior andpsychoso-cial development: a longitudinal study of youth. New York: Academic Press; 1977.
36. Jessor R. Risk behavior in adolescence: a psychoso-cial framework for understanding and action. J Adolesc Health. 1991;12:597-605.
37. Reid LW, Elifson KW, Sterk CE. Hug drug or thug drug? Ecstasy use and aggressive behavior. Violence Vict. 2007;22:104-19.
38. Ferdinand RF, Blum M, Verhulst FC. Psychopathol-ogy in adolescence predicts substance use in young adulthood. Addiction. 2001;96:861-70.
39. Khantzian EJ. The self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence. Am J Psychiatry. 1985;142:1259-64.
40. Khantzian EJ. The self-medication hypothesis of substance use disorders: a reconsideration and recent applications. Harv Rev Psychiatry. 1997;4:231-44.
41. Reay JL, Hamilton C, Kennedy DO, Scholey AB. MDMA polydrug users show process-specific central executive impairments coupled with impaired social and emotional judgement processes. J Psychopharmacol. 2006;20:385-8.